OCUGEN, INC. Earnings Per Share, Basic and Diluted
OCUGEN, INC. (OCGN) reported Earnings Per Share, Basic and Diluted of -$0.04 per share for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-07.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-05-07
- OCUGEN, INC. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.04.
- OCUGEN, INC. earnings per share, basic and diluted for the quarter ending 2020-12-31 was -$0.02, a 106.83% decline year-over-year.
- OCUGEN, INC. earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$0.07.
- OCUGEN, INC. earnings per share, basic and diluted for the quarter ending 2020-06-30 was -$0.19.
- OCUGEN, INC. earnings per share, basic and diluted for fiscal 2020 was -$0.31.
- OCUGEN, INC. earnings per share, basic and diluted for fiscal 2019 was -$1.46.
- OCUGEN, INC. earnings per share, basic and diluted for fiscal 2018 was -$3.67.
- OCUGEN, INC. earnings per share, basic and diluted for fiscal 2015 was -$2.42.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|---|---|
| 2021-03-31 | -$0.04 10-Q · filed 2021-05-07 | -$0.06 derived: net income ÷ weighted average shares · filed 2022-02-28 | -$0.13 derived: net income ÷ weighted average shares · filed 2022-02-28 | -$0.26 derived: net income ÷ weighted average shares · filed 2022-02-28 | ||
| 2020-12-31 | -$0.02 derived: net income ÷ weighted average shares · filed 2022-02-28 | -$0.09 derived: net income ÷ weighted average shares · filed 2022-02-28 | -$0.23 derived: net income ÷ weighted average shares · filed 2022-02-28 | -$0.31 10-K · filed 2021-03-19 | ||
| 2020-09-30 | -$0.07 10-Q · filed 2020-11-06 | -$0.24 derived: net income ÷ weighted average shares · filed 2021-11-09 | -$0.33 10-Q · filed 2020-11-06 | |||
| 2020-06-30 | -$0.19 10-Q · filed 2020-08-14 | -$0.30 10-Q · filed 2020-08-14 | ||||
| 2020-03-31 | -$0.07 10-Q · filed 2021-05-07 | |||||
| 2019-12-31 | $0.33 derived: net income ÷ weighted average shares · filed 2022-02-28 | -$0.47 derived: net income ÷ weighted average shares · filed 2022-02-28 | -$0.83 derived: net income ÷ weighted average shares · filed 2022-02-28 | -$1.46 10-K · filed 2021-03-19 | ||
| 2019-09-30 | -$3.55 10-Q · filed 2020-11-06 | -$4.22 derived: net income ÷ weighted average shares · filed 2020-11-06 | -$5.59 10-Q · filed 2020-11-06 | |||
| 2019-06-30 | -$0.58 10-Q · filed 2020-08-14 | -$0.03 10-Q · filed 2019-08-09 | -$1.80 10-Q · filed 2020-08-14 | -$0.14 10-Q · filed 2019-08-09 | ||
| 2019-03-31 | -$1.27 10-Q · filed 2020-05-08 | -$0.12 10-Q · filed 2019-05-15 | ||||
| 2018-12-31 | -$2.13 derived: net income ÷ weighted average shares · filed 2020-03-27 | $0.02 derived: net income ÷ weighted average shares · filed 2020-03-27 | -$3.67 10-K · filed 2020-03-27 | |||
| 2018-09-30 | -$0.39 10-Q · filed 2019-11-12 | -$2.47 10-Q · filed 2019-11-12 | ||||
| 2018-06-30 | -$0.51 8-K/A · filed 2019-10-07 | -$0.13 10-Q · filed 2018-08-09 | -$1.00 8-K/A · filed 2019-10-07 | -$0.64 10-Q · filed 2018-08-09 | ||
| 2018-03-31 | -$0.52 10-Q · filed 2019-05-15 | |||||
| 2017-09-30 | -$0.23 10-Q · filed 2017-11-09 | -$0.74 10-Q · filed 2017-11-09 | ||||
| 2017-06-30 | -$0.25 10-Q · filed 2018-08-09 | -$0.51 10-Q · filed 2018-08-09 | ||||
| 2017-03-31 | -$0.27 10-Q · filed 2018-05-10 | |||||
| 2016-09-30 | -$0.70 10-Q · filed 2017-11-09 | -$1.90 10-Q · filed 2017-11-09 | ||||
| 2016-06-30 | -$0.61 10-Q · filed 2017-08-10 | -$1.20 10-Q · filed 2017-08-10 | ||||
| 2016-03-31 | -$0.60 10-Q · filed 2017-05-11 | |||||
| 2015-12-31 | -$2.42 10-K · filed 2016-03-10 | |||||
| 2015-09-30 | -$0.61 10-Q · filed 2016-11-10 | -$1.79 10-Q · filed 2016-11-10 | ||||
| 2015-06-30 | -$0.58 10-Q · filed 2016-08-11 | -$1.18 10-Q · filed 2016-08-11 | ||||
| 2015-03-31 | -$0.60 10-Q · filed 2016-05-12 | |||||
| 2014-12-31 | -$6.85 10-K · filed 2016-03-10 | |||||
| 2014-09-30 | -$19.38 10-Q · filed 2015-11-12 | -$45.49 10-Q · filed 2015-11-12 | ||||
| 2014-06-30 | -$19.85 10-Q · filed 2015-08-12 | -$25.91 10-Q · filed 2015-08-12 | ||||
| 2014-03-31 | -$5.90 10-Q · filed 2015-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |